Predictive Factors of Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer

Publisher： Karger

E-ISSN： 1423-0232|78|5-6|369-375

ISSN： 0030-2414

Source： Oncology, Vol.78, Iss.5-6, 2010-08, pp. : 369-375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Complete clinical response to neoadjuvant chemoradiotherapy for rectal cancer: an Australasian perspective

By  

ANZ JOURNAL OF SURGERY, Vol. 85, Iss. 3, 2015-03 ,pp. : 103-104

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review

By  

COLORECTAL DISEASE, Vol. 17, Iss. 10, 2015-10 ,pp. : 849-861

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictive Factors for Response to Neoadjuvant Therapy in Breast Cancer

By  

Oncology Research and Treatment, Vol. 37, Iss. 10, 2014-09 ,pp. : 563-568

Karger

Access to resources Recommend Favorite

PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

By  

HISTOPATHOLOGY, Vol. 66, Iss. 7, 2015-06 ,pp. : 991-1002

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence‐free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy

By  

CANCER, Vol. 119, Iss. 24, 2013-12 ,pp. : 4231-4241

John Wiley & Sons Inc

Access to resources Recommend Favorite